October 26, 2015.
The global biopharmaceuticals market was valued at $160, 440 million in 2014, and it is expected to grow with a CAGR of 9.6% during the period 2015-2020, according to a report from P&S Market Research. The global recombinant human insulin market segment is expected to witness fastest growth during the forecast period, states the report. The oncology segment accounted for the largest market in the global biopharmaceuticals market in 2014; and is expected to witness growth with 11.1% CAGR during the period 2015-2020. A detailed TOC for the report, Global Biopharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Type, can be accessed here and sample pages can be found here.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.